Literature DB >> 9373575

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

J A Kanis1, P Delmas, P Burckhardt, C Cooper, D Torgerson.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9373575     DOI： 10.1007/bf01623782

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  1 in total

1.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507
  1 in total
  182 in total

1.  Influence of bone densitometry results on the treatment of osteoporosis.

Authors:  N S Fitt; S L Mitchell; A Cranney; K Gulenchyn; M Huang; P Tugwell
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS).

Authors:  M Pedrazzoni; G Girasole; F Bertoldo; G Bianchi; C Cepollaro; A Del Puente; S Giannini; S Gonnelli; D Maggio; C Marcocci; S Minisola; E Palummeri; M Rossini; L Sartori; L Sinigaglia
Journal:  Osteoporos Int       Date:  2003-10-03       Impact factor: 4.507

Review 3.  Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review.

Authors:  M Hamidi; B A Boucher; A M Cheung; J Beyene; P S Shah
Journal:  Osteoporos Int       Date:  2010-12-17       Impact factor: 4.507

4.  Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.

Authors:  Guenther G Steger; Rupert Bartsch
Journal:  Ther Adv Med Oncol       Date:  2011-09       Impact factor: 8.168

5.  Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention.

Authors:  Deborah A Levine; Kenneth G Saag; Linda L Casebeer; Cathleen Colon-Emeric; Kenneth W Lyles; Richard M Shewchuk
Journal:  J Am Med Dir Assoc       Date:  2006-07-17       Impact factor: 4.669

6.  An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines.

Authors:  R Baddoura; H Awada; J Okais; M Salamoun; G Ayoub; N Ziadé; G El Hajj-Fuleihan
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

7.  Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.

Authors:  J A Stakkestad; L I Benevolenskaya; J J Stepan; A Skag; A Nordby; E Oefjord; A Burdeska; I Jonkanski; P Mahoney
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

8.  A triage strategy based on clinical risk factors for selecting elderly women for treatment or bone densitometry: the EPIDOS prospective study.

Authors:  P Dargent-Molina; S Piault; G Bréart
Journal:  Osteoporos Int       Date:  2004-11-27       Impact factor: 4.507

Review 9.  Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?

Authors:  Mary H Hohenhaus; Kelly A McGarry; Nananda F Col
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years.

Authors:  E D Newman; W T Ayoub; R H Starkey; J M Diehl; G C Wood
Journal:  Osteoporos Int       Date:  2003-02-18       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.